9,10 An algorithm for treating TNF alpha inhibitor psoriasiform eruptions has been proposed and is based on severity of skin eruption and control of the underlying disease 11 : If the skin eruption is mild and the underlying disease is controlled, continue the TNF alpha inhibitor and treat the eruption topically If the skin eruption is mild but the underlying disease is not controlled, switching within the same class is reasonable If the skin eruption is moderate to severe and the underlying disease is controlled, switching within the same class is reasonable If the skin eruption is moderate to severe and the disease is not well controlled, discontinuing TNF alpha inhibitors altogether is warranted
Your body is adjusting, and thats normal
The complete guide on GLP-1 and breastfeeding reviews the available evidence, but the decision to use any GLP-1 medication while nursing should involve a thorough risk-benefit discussion with your doctor
Users taking various tirzepatide doses report different severity levels, with higher doses producing more pronounced symptoms in most cases
In addition, semaglutide is most effective as a chronic weight management aid when combined with lifestyle changes like a reduced-calorie diet and regular exercise